Browse result page of THPdb

The total number entries retrieved from this search are 53

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1028	ThPPIDTh1005	NameEtanercept	Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view	Length255	Functional ClassificationIIa	DiseaseImmunological	BrandEnbrel	CompanyImmunex Corp	Physical AppearanceLyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1029	ThPPIDTh1005	NameEtanercept	Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view	Length255	Functional ClassificationIIa	DiseaseImmunological	BrandEnbrel Sureclick	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1049	ThPPIDTh1008	NamePeginterferon alfa-2a	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandPegasys	CompanyHoffman-La Roche Inc	Physical AppearanceSterile, preservative-free, colorless to light yellow injectable solution	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1110	ThPPIDTh1015	NameInterferon alfa-n3	Peptide SequenceAlpha-2A:CDLPQTHSLG< Full view	Length235	Functional ClassificationIb	DiseaseImmunological	BrandAlferon	CompanyInterferon Sciences Inc.	Physical AppearanceSolution	Route of AdministartionInjection	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1111	ThPPIDTh1015	NameInterferon alfa-n3	Peptide SequenceAlpha-2A:CDLPQTHSLG< Full view	Length235	Functional ClassificationIb	DiseaseImmunological	BrandAlferon LDO	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1112	ThPPIDTh1015	NameInterferon alfa-n3	Peptide SequenceAlpha-2A:CDLPQTHSLG< Full view	Length235	Functional ClassificationIb	DiseaseImmunological	BrandAlferon N Injection	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1117	ThPPIDTh1016	NamePegfilgrastim	Peptide SequenceMTPLGPASSLPQSFLLKCLE Full view	Length175	Functional ClassificationIb	DiseaseImmunological	BrandNeulasta	CompanyAmgen Inc.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents, Anti-neutropenic agents	TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase
ID1120	ThPPIDTh1017	NameSargramostim	Peptide SequenceAPARSPSPSTQPWEHVNAIQ Full view	Length127	Functional ClassificationIb	DiseaseImmunological	BrandLeucomax	CompanyNovartis	Physical AppearanceSolution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryImmunosuppressive Agents	TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1121	ThPPIDTh1017	NameSargramostim	Peptide SequenceAPARSPSPSTQPWEHVNAIQ Full view	Length127	Functional ClassificationIb	DiseaseImmunological	BrandLeukine	CompanyBerlex Laboratories Inc	Physical AppearanceSterile, preserved (1.1% benzyl alcohol), injectable solution (500 mcg/mL) and also as sterile, white, preservative free lyophilized powder (250 mcg) that requires reconstitution with 1 mL sterile water for Injection	Route of AdministartionSubcutaneous Injection (SC) or Intravenous infusion (IV)	CategoryImmunosuppressive Agents	TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1135	ThPPIDTh1019	NamePeginterferon alfa-2b	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandPEG-Intron	CompanySchering Corp	Physical AppearancePowder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1136	ThPPIDTh1019	NamePeginterferon alfa-2b	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandUnitron PEG	CompanyN.A.	Physical AppearanceLyophilized powder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1180	ThPPIDTh1023	NameAnakinra	Peptide SequenceMRPSGRKSSKMQAFRIWDVN Full view	Length153	Functional ClassificationIIa	DiseaseImmunological	BrandKineret	CompanyAmgen Inc	Physical AppearanceSterile, clear, colorless-to-white, preservative free solution	Route of AdministartionSubcutaneous (SC) administration	CategoryImmunosuppressive Agents, Anti-rheumatic agents	TargetInterleukin-1 receptor type 1
ID1193	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandCivacir	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1194	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandFlebogamma	CompanyInstituto Grifols SA	Physical AppearanceSterile, clear or slightly opalescent and colorless to pale yellow, liquid	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1195	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandGamunex	CompanyTalecris Biotherapeutics	Physical AppearanceSterile solution	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1226	ThPPIDTh1030	NameInterferon gamma-1b	Peptide SequenceCYCQDPYVKEAENLKKYFNA Full view	Length146	Functional ClassificationIb	DiseaseImmunological	BrandActimmune	CompanyInterMune Inc	Physical AppearanceSterile, clear, colorless solution	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents	TargetInterferon gamma receptor 1,Interferon gamma receptor 2
ID1316	ThPPIDTh1044	NameAdalimumab	Peptide SequenceLight-chain:DIQMTQS< Full view	Length230	Functional ClassificationIc	DiseaseImmunological	BrandHumira	CompanyAbbott Laboratories	Physical AppearanceSterile, preservative-free solution	Route of AdministartionSubcutaneous administration	CategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents	TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1317	ThPPIDTh1044	NameAdalimumab	Peptide SequenceLight-chain:DIQMTQS< Full view	Length230	Functional ClassificationIc	DiseaseOsteological	BrandHumira Pen	CompanyAbbott Laboratories	Physical AppearanceSterile, preservative-free solution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents	TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1341	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandAvonex	CompanyBiogen Inc	Physical AppearanceLyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector.	Route of AdministartionIntramuscular Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1342	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBetaferon	CompanyBayer	Physical AppearancePowder and solvent that are made upto make solution.	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1343	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBetaseron	CompanyMerck	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1344	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBlastoferon	CompanySidus	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1345	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandExtavia	CompanyNovartis	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1346	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandRebif	CompanyMerck	Physical AppearanceSterile solution in a prefilled syringe or REBIF Rebidose autoinjector	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1368	ThPPIDTh1054	NameInfliximab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandREMICADE	CompanyCentocor Inc	Physical AppearanceSterile, white, lyophilized powder, following reconstitution with 10 mL of Sterile Water for Injection, USP, the resulting pH is approximately 7.2.	Route of AdministartionIntravenous infusion	CategoryAntirheumatic Agents, Anti-Inflammatory Agents, Non-Steroidal, Dermatologic Agents, Gastrointestinal Agents and Immunosuppressive Agents	TargetTumor necrosis factor
ID1376	ThPPIDTh1057	NameInterferon beta-1b	Peptide SequenceMSYNLLGFLQRSSNFQSQKL Full view	Length166	Functional ClassificationIb	DiseaseImmunological	BrandBetaseron	CompanyBayer	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryAdjuvants, Immunologic and Immunosuppressive Agents	TargetN.A.
ID1377	ThPPIDTh1057	NameInterferon beta-1b	Peptide SequenceMSYNLLGFLQRSSNFQSQKL Full view	Length166	Functional ClassificationIb	DiseaseImmunological	BrandBetaferon	CompanyBayer	Physical AppearancePowder and solvent that are made upto make solution.	Route of AdministartionSubcutaneous Injection	CategoryAdjuvants, Immunologic and Immunosuppressive Agents	TargetN.A.
ID1378	ThPPIDTh1057	NameInterferon beta-1b	Peptide SequenceMSYNLLGFLQRSSNFQSQKL Full view	Length166	Functional ClassificationIb	DiseaseImmunological	BrandExtavia	CompanyNovartis	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryAdjuvants, Immunologic and Immunosuppressive Agents	TargetN.A.
ID1379	ThPPIDTh1058	NameInterferon alfacon-1	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological/Infectious	BrandINFERGEN	CompanyKadmon Pharmaceuticals, LLC.	Physical AppearanceSterile, clear, colorless, preservative-free liquid	Route of AdministartionSubcutaneous Injection	CategoryAntiviral Agents and Immunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1398	ThPPIDTh1063	NameBasiliximab	Peptide SequenceHeavy Chain: QLQQSGT Full view	Length657	Functional ClassificationIIa	DiseaseImmunological	BrandSimulect	CompanyNovartis	Physical AppearanceSterile lyophilisate which is available in 6 mL colorless glass vials and is available in 10 mg and 20 mg strength	Route of Administartionintravenous infusion mainly or bolus (if no allergic reactions occurs)	CategoryImmunosuppressive Agents	TargetN.A.
ID1400	ThPPIDTh1064	NameMuromonab	Peptide SequenceHeavy Chain: QVQLQQS Full view	Length664	Functional ClassificationIIa	DiseaseImmunological	BrandORTHOCLONE OKT3 STERILE SOLUTION	CompanyCentocor Ortho Biotech, L.P.	Physical AppearanceSterile Solution is a murine monoclonal antibody to the CD3 antigen of human T cells which functions as an immunosuppressant.	Route of AdministartionFor Intravenous Use Only	CategoryImmunologic Factors and Immunosuppressive Agents	TargetN.A.
ID1442	ThPPIDTh1078	NameEfalizumab	Peptide SequenceLight Chain:DIQMTQSP Full view	Length229	Functional ClassificationIIa	DiseaseImmunological	BrandRAPTIVA	CompanyGenentech, Inc.	Physical AppearanceSterile, white to off-white, lyophilized powder in single-use glass vials	Route of AdministartionSubcutaneous injection.ÂÂÂ	CategoryImmunosuppressive Agents	TargetIduronic acid
ID1449	ThPPIDTh1081	NameAntithymocyte Globulin	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandAntithymocyte globulin	CompanyPfizer	Physical AppearanceN.A.	Route of AdministartionIntravenous infusion	CategoryImmunologic Factors and Immunosuppressive Agents	TargetN.A.
ID1451	ThPPIDTh1082	NameFilgrastim	Peptide SequenceMTPLGPASSLPQSFLLKCLE Full view	Length175	Functional ClassificationIb	DiseaseImmunological	BrandN.A.	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Antineutropenic Agents and Hematopoietic Agents	TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor
ID1456	ThPPIDTh1086	NameInterferon Alfa-2B, Recombinant	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandINTRON® A	CompanyMerck	Physical AppearancePowder or solution	Route of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injection	CategoryImmunosuppressive Agents	TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin
ID1466	ThPPIDTh1090	NameDaclizumab	Peptide SequenceQVQLVQSGAEVKKPGSSVKV Full view	Length674	Functional ClassificationIIa	DiseaseImmunologicals	BrandZenapax	CompanyRoche	Physical AppearanceClear, sterile, colorless concentrate for further dilution and intravenous administration	Route of AdministartionIntravenous injection	CategoryImmunosuppressive Agents	TargetFusion glycoprotein F0,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1495	ThPPIDTh1102	NameAbatacept	Peptide SequenceMHVAQPAVVLASSRGIASFV Full view	Length357	Functional ClassificationIIa	DiseaseImmunological	BrandORENCIA	CompanyBristol-Myers Squibb	Physical AppearanceLyophilized powder, supplied as a sterile, white, preservative-free, lyophilized powder for intravenous administration	Route of AdministartionIntravenous infusion and Subcutaneous injection	CategoryAntirheumatic Agents and Immunosuppressive Agents	TargetT-lymphocyte activation antigen CD80,T-lymphocyte activation antigen CD86
ID1562	ThPPIDTh1122	NameRilonacept	Peptide Sequencerilonacept|Homo sapi Full view	Length880	Functional ClassificationIIa	DiseaseImmunological	BrandArcalyst	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, white to off-white, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterleukin-1 beta,Interleukin-1 alpha,Interleukin-1 receptor antagonist protein
ID1596	ThPPIDTh1126	NameBelatacept	Peptide SequenceMHVAQPAVVLASSRGIASFV Full view	Length357	Functional ClassificationIIa	DiseaseImmunological	BrandNulojix	CompanyBristol-Myers Squibb	Physical AppearanceSterile, white or off-white lyophilized powder	Route of AdministartionIntravenous injection	CategoryAntirheumatic Agents and Immunosuppressive Agents	TargetT-lymphocyte activation antigen CD86,T-lymphocyte activation antigen CD80
ID1644	ThPPIDTh1147	NameNatalizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Immunological	BrandTysabri	CompanyBiogen Idec Inc.	Physical AppearanceSterile, colorless, and clear to slightly opalescent concentrate	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive agents	TargetN.A.
ID1708	ThPPIDTh1170	NameBlinatumomab	Peptide SequenceDIQLTQSPASLAVSLGQRAT Full view	Length504	Functional ClassificationIIIc	DiseaseCancer/Genetic	BrandBlincyto	CompanyAMGEN	Physical AppearanceLyophilized Powder for intravenous administration	Route of AdministartionIntravenous	CategoryAntineoplastic Agents, Immunosuppressive Agents, Monoclonal antibodies, Antineoplastic and Immunomodulating Agents	TargetB-lymphocyte antigen CD19; T-cell surface glycoprotein CD3 delta chain
ID1785	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandBivigam	CompanyKedrion Biopharma, Inc.	Physical AppearanceInjection, Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1786	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandBivigam	CompanyBiotest Pharmaceuticals Corporation	Physical AppearanceInjection, Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1788	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandCarimune Nanofiltered	CompanyCsl Behring Ag	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1791	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandFlebogamma Dif	CompanyGRIFOLS USA, LLC	Physical AppearanceInjection, Solution	Route of AdministartionIntravenous	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1793	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandGamastan	CompanyCutter Med & Biol, Division Of Miles Canada Ltd.	Physical Appearanceliquid	Route of AdministartionIntramuscular	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1794	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandGamastan S/d	CompanyGRIFOLS USA, LLC	Physical AppearanceInjection	Route of AdministartionIntramuscular	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1795	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandHyqvia	CompanyBaxalta Us Inc.	Physical AppearanceLiquid	Route of AdministartionIntravenous infusion	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1796	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandIveegam Immuno 5000mg (iv)	CompanyBaxter Ag	Physical AppearanceNA	Route of AdministartionNA	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1798	ThPPIDTh1192	NameUstekinumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseInfectious Disease	BrandStelara	CompanyJanssen Biotech, Inc.	Physical AppearanceSolution fro Injection	Route of AdministartionSubcutaneous	CategoryDeramtologic agent, Immunosuppressive agent, antineoplastic agent	TargetInterleukin-12 subunit beta